As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

Background Pathogenesis of cutaneous lupus is unclear. Skin harbors at least three subsets of dendritic cells (DC): Langerhans cells (LC) that reside in the epidermis, langerin-expressing dermal DC ...

Objectives To investigate dry eye disease (DED) in patients affected by systemic lupus erythematosus (SLE). Methods We conducted a systematic search of the literature on PubMed, EMBASE and the ...

Objective Systemic lupus erythematosus (SLE) can negatively impact patients’ social participation. The aim of this study was to identify the determinants of social participation in patients with ...

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

Changes in serum GR levels during the conversion of the disease activity state in patients with SLE. GR, glutathione reductase; SLEDAI 2000, Systematic Lupus Erythematosus Disease Activity Index 2000; ...

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...